nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—CHRM3—nephrolithiasis	0.878	1	CbGaD
Propiomazine—CHRM3—ureter—nephrolithiasis	0.00409	0.565	CbGeAlD
Propiomazine—HTR2A—urine—nephrolithiasis	0.000789	0.109	CbGeAlD
Propiomazine—Chlorprothixene—CHRM3—nephrolithiasis	0.000766	0.234	CrCbGaD
Propiomazine—Methotrimeprazine—CHRM3—nephrolithiasis	0.000692	0.212	CrCbGaD
Propiomazine—Promethazine—CHRM3—nephrolithiasis	0.000681	0.209	CrCbGaD
Propiomazine—Promazine—CHRM3—nephrolithiasis	0.000599	0.184	CrCbGaD
Propiomazine—ADRA1B—renal system—nephrolithiasis	0.000531	0.0734	CbGeAlD
Propiomazine—Chlorpromazine—CHRM3—nephrolithiasis	0.000527	0.162	CrCbGaD
Propiomazine—ADRA1B—kidney—nephrolithiasis	0.000514	0.0709	CbGeAlD
Propiomazine—CHRM3—renal system—nephrolithiasis	0.000325	0.0449	CbGeAlD
Propiomazine—CHRM3—kidney—nephrolithiasis	0.000314	0.0434	CbGeAlD
Propiomazine—ADRA1A—renal system—nephrolithiasis	0.000298	0.0412	CbGeAlD
Propiomazine—DRD4—Signaling by GPCR—RGS14—nephrolithiasis	0.00021	0.00189	CbGpPWpGaD
Propiomazine—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000208	0.00187	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000208	0.00187	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—RGS14—nephrolithiasis	0.000207	0.00186	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.000205	0.00185	CbGpPWpGaD
Propiomazine—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000205	0.00184	CbGpPWpGaD
Propiomazine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000204	0.00184	CbGpPWpGaD
Propiomazine—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000203	0.00183	CbGpPWpGaD
Propiomazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000202	0.00182	CbGpPWpGaD
Propiomazine—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000201	0.00181	CbGpPWpGaD
Propiomazine—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0002	0.0018	CbGpPWpGaD
Propiomazine—DRD4—GPCR ligand binding—CHRM3—nephrolithiasis	0.0002	0.0018	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.000198	0.00178	CbGpPWpGaD
Propiomazine—CHRM4—GPCR ligand binding—CHRM3—nephrolithiasis	0.000197	0.00177	CbGpPWpGaD
Propiomazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000193	0.00174	CbGpPWpGaD
Propiomazine—HTR2A—renal system—nephrolithiasis	0.000193	0.0267	CbGeAlD
Propiomazine—DRD1—Signaling by GPCR—RGS14—nephrolithiasis	0.000189	0.0017	CbGpPWpGaD
Propiomazine—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.000189	0.0017	CbGpPWpGaD
Propiomazine—HTR2A—kidney—nephrolithiasis	0.000187	0.0258	CbGeAlD
Propiomazine—ADRA1D—Signaling by GPCR—RGS14—nephrolithiasis	0.000186	0.00168	CbGpPWpGaD
Propiomazine—DRD4—GPCR ligand binding—PTH—nephrolithiasis	0.000182	0.00164	CbGpPWpGaD
Propiomazine—CHRM4—GPCR ligand binding—PTH—nephrolithiasis	0.00018	0.00162	CbGpPWpGaD
Propiomazine—DRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00018	0.00162	CbGpPWpGaD
Propiomazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000178	0.0016	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.000178	0.0016	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.000177	0.0016	CbGpPWpGaD
Propiomazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000175	0.00158	CbGpPWpGaD
Propiomazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000175	0.00157	CbGpPWpGaD
Propiomazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000174	0.00157	CbGpPWpGaD
Propiomazine—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.000172	0.00155	CbGpPWpGaD
Propiomazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000172	0.00155	CbGpPWpGaD
Propiomazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000172	0.00155	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00017	0.00153	CbGpPWpGaD
Propiomazine—DRD1—GPCR ligand binding—PTH—nephrolithiasis	0.000164	0.00148	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR ligand binding—PTH—nephrolithiasis	0.000162	0.00146	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—RGS14—nephrolithiasis	0.000161	0.00145	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000157	0.00141	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—DGKH—nephrolithiasis	0.000156	0.0014	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.000155	0.00139	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000154	0.00139	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000154	0.00139	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—DGKH—nephrolithiasis	0.000154	0.00139	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.000154	0.00138	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000154	0.00138	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000153	0.00138	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000152	0.00137	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000151	0.00136	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.000147	0.00133	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000147	0.00132	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—ADCY10—nephrolithiasis	0.000146	0.00131	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—ADCY10—nephrolithiasis	0.000144	0.00129	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.000143	0.00128	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—DGKH—nephrolithiasis	0.000142	0.00128	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.000141	0.00127	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00014	0.00126	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00014	0.00126	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.00014	0.00126	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—DGKH—nephrolithiasis	0.00014	0.00126	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000139	0.00126	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000139	0.00125	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.000139	0.00125	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000138	0.00124	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.000138	0.00124	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000137	0.00124	CbGpPWpGaD
Propiomazine—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000136	0.00122	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.000135	0.00121	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.000134	0.0012	CbGpPWpGaD
Propiomazine—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000133	0.0012	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000133	0.0012	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000133	0.0012	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.000131	0.00118	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000131	0.00118	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000131	0.00118	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000129	0.00117	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.000128	0.00115	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000126	0.00113	CbGpPWpGaD
Propiomazine—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.000124	0.00112	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—RGS14—nephrolithiasis	0.000124	0.00112	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—RGS14—nephrolithiasis	0.000122	0.0011	CbGpPWpGaD
Propiomazine—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.000122	0.0011	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000122	0.0011	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000121	0.00109	CbGpPWpGaD
Propiomazine—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000121	0.00109	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.00012	0.00108	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.00012	0.00108	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00012	0.00108	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.000117	0.00105	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000115	0.00104	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000113	0.00102	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000112	0.00101	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—RGS14—nephrolithiasis	0.000112	0.001	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000111	0.001	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	0.00011	0.000991	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000109	0.000982	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000107	0.000967	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000107	0.000959	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000106	0.000955	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000104	0.00094	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000104	0.000939	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000104	0.000937	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000104	0.000934	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000103	0.000931	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—PTH—nephrolithiasis	0.000103	0.000929	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000102	0.000922	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—CHRM3—nephrolithiasis	0.000102	0.000922	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000102	0.00092	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	0.000102	0.000916	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000102	0.000914	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	0.000101	0.00091	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0001	0.000902	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	9.9e-05	0.000892	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—GRHPR—nephrolithiasis	9.82e-05	0.000884	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	9.74e-05	0.000877	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	9.74e-05	0.000877	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	9.72e-05	0.000875	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	9.69e-05	0.000873	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	9.67e-05	0.000871	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	9.66e-05	0.00087	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	9.63e-05	0.000867	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	9.57e-05	0.000861	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	9.54e-05	0.000859	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	9.54e-05	0.000859	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	9.47e-05	0.000853	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	9.45e-05	0.000851	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	9.42e-05	0.000848	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	9.39e-05	0.000846	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—PTH—nephrolithiasis	9.37e-05	0.000843	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	9.3e-05	0.000837	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	9.28e-05	0.000836	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	9.27e-05	0.000835	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	9.24e-05	0.000832	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	9.22e-05	0.00083	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	9.16e-05	0.000825	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	9.13e-05	0.000822	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	9.1e-05	0.000819	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	8.85e-05	0.000797	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—AGXT—nephrolithiasis	8.75e-05	0.000788	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	8.68e-05	0.000782	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—PTH—nephrolithiasis	8.43e-05	0.000759	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—RGS14—nephrolithiasis	8.42e-05	0.000758	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—DGKH—nephrolithiasis	8.37e-05	0.000753	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—ATP6V0A4—nephrolithiasis	8.37e-05	0.000753	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	8.32e-05	0.000749	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	8.31e-05	0.000749	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	8.28e-05	0.000746	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	8.27e-05	0.000744	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	8.25e-05	0.000743	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	8.25e-05	0.000743	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	8.24e-05	0.000742	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	8.21e-05	0.00074	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	8.13e-05	0.000732	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	8.11e-05	0.00073	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	7.94e-05	0.000715	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	7.9e-05	0.000712	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.9e-05	0.000712	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	7.89e-05	0.00071	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	7.66e-05	0.00069	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	7.6e-05	0.000685	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	7.55e-05	0.00068	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	7.54e-05	0.000679	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.53e-05	0.000678	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—DGKH—nephrolithiasis	7.53e-05	0.000678	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	7.53e-05	0.000678	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	7.5e-05	0.000675	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—APRT—nephrolithiasis	7.44e-05	0.00067	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—SLC26A1—nephrolithiasis	7.44e-05	0.00067	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.43e-05	0.000669	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	7.43e-05	0.000669	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	7.4e-05	0.000667	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	7.38e-05	0.000665	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	7.21e-05	0.00065	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	7.01e-05	0.000631	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	6.96e-05	0.000627	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	6.9e-05	0.000622	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	6.9e-05	0.000621	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	6.88e-05	0.00062	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	6.86e-05	0.000618	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	6.85e-05	0.000617	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	6.84e-05	0.000616	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	6.83e-05	0.000615	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	6.81e-05	0.000613	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	6.77e-05	0.00061	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	6.75e-05	0.000608	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	6.72e-05	0.000605	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	6.71e-05	0.000604	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.44e-05	0.00058	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	6.44e-05	0.00058	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—PTH—nephrolithiasis	6.37e-05	0.000573	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	6.26e-05	0.000564	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	6.25e-05	0.000563	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	6.23e-05	0.000561	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	6.21e-05	0.000559	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.17e-05	0.000555	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	6.17e-05	0.000555	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	6.15e-05	0.000554	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	6.13e-05	0.000552	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CHRM3—nephrolithiasis	6.05e-05	0.000545	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	5.97e-05	0.000537	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	5.71e-05	0.000515	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.69e-05	0.000512	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—DGKH—nephrolithiasis	5.69e-05	0.000512	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	5.6e-05	0.000504	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.6e-05	0.000504	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	5.58e-05	0.000503	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.58e-05	0.000503	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.57e-05	0.000501	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	5.57e-05	0.000501	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.55e-05	0.0005	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	5.55e-05	0.0005	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—PTH—nephrolithiasis	5.53e-05	0.000498	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	5.49e-05	0.000495	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.49e-05	0.000495	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.48e-05	0.000493	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	5.48e-05	0.000493	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—PTH—nephrolithiasis	5.46e-05	0.000491	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	5.45e-05	0.00049	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	5.37e-05	0.000484	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—AQP1—nephrolithiasis	5.3e-05	0.000478	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—PTH—nephrolithiasis	5.23e-05	0.000471	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—PTH—nephrolithiasis	4.98e-05	0.000448	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	4.91e-05	0.000443	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	4.66e-05	0.00042	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	4.46e-05	0.000402	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PTH—nephrolithiasis	4.26e-05	0.000384	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	4.11e-05	0.00037	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	4.08e-05	0.000367	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	4.05e-05	0.000364	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	4.04e-05	0.000364	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	4.02e-05	0.000362	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	3.97e-05	0.000358	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	3.96e-05	0.000357	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PTH—nephrolithiasis	3.76e-05	0.000339	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PTH—nephrolithiasis	3.7e-05	0.000333	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PTH—nephrolithiasis	3.69e-05	0.000332	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PTH—nephrolithiasis	3.68e-05	0.000331	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PTH—nephrolithiasis	3.67e-05	0.00033	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PTH—nephrolithiasis	3.63e-05	0.000327	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	3.62e-05	0.000326	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—SPP1—nephrolithiasis	2.78e-05	0.00025	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	2.74e-05	0.000247	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	2.62e-05	0.000236	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—SPP1—nephrolithiasis	2.5e-05	0.000225	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	2.47e-05	0.000222	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	2.14e-05	0.000193	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	2.05e-05	0.000184	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—SPP1—nephrolithiasis	1.89e-05	0.00017	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	1.86e-05	0.000167	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	1.85e-05	0.000167	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.85e-05	0.000166	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.84e-05	0.000166	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.82e-05	0.000164	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	1.82e-05	0.000164	CbGpPWpGaD
